期刊文献+

新型药用辅料乙交酯丙交酯共聚物中单体残留量的测定 被引量:2

Determination of residual lactic and glycolic contents in the new excipient poly(lactic-co-glycolic acid)
原文传递
导出
摘要 目的:建立内标法测定乙交酯丙交酯共聚物(PLGA)中单体残留量的气相色谱检测方法。方法:采用气相色谱法进行测定:内标物为乙酸丁酯;色谱柱为DB-5柱(30m×0.53mm,5um);进样口温度为250℃;分流比10:1;载气为氮气;柱温为135℃;检测器为火焰离子检测器(FID),检测器温度为300℃;进样量为3uL。结果:采用气相色谱法测定PLGA中乙交酯与丙交酯的含量,乙交酯与丙交酯的线性范围分别为17.67~83.30和33.33~266.70ug·mL-1,加标回收率分别为99.0%和100.6%,相对标准偏差分别为0.7%和1.0%。结论:经方法学验证,该法简便、快捷、灵敏度高、结果准确,适用于PLGA中乙交酯与丙交酯的检测。 Objective: To establish a quantitative method for determination of lactic and glycolic contents in PLGA by gas chromatography with internal standard substance. Methods: N-butyl acetate was used as an internal standard substance and a capillary gas chromatographic method was carried out. DB-5 capillary column (30 m × 0.53 mm,5 um) was used, the injection port temperature was 250 ℃ , and the split ratio was 10: 1. The carrier gas was nitrogen and the initial column temperature was 135 ℃. The temperature of FID was set at 300 ℃ , and the sample volume was set at 3 uL. Results: The concentration of glycolic and lactic was linearly within 17.67 - 83.30 and 33.33 -266.70 ug. mL-1, respectively. The recovery of glycolic and lactic was 99.0% and 100.6% , and the relative standard deviation was 0.7% and 1.0%. Conclusion: The method is simple, rapid, sensitive and accurate. It is suitable for the content determination of residual lactic and glycolic in PLGA.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第4期403-406,共4页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项(2013ZX09509106)
关键词 内标 气相色谱法 PLGA 乙交酯 丙交酯 internal standard substance gas chromatography PLGA lactic glycolic
  • 相关文献

参考文献4

二级参考文献92

  • 1DEREK T,MANMOHAN S, RAJESH K. Poly( lactide-co-glycolide) micropartlcles for the development of single-dose controlled- release vaccines[ J]. Adv Drug Deliv Rev, 1998,32 (10) :225 - 246.
  • 2LEACH WT,SIMPSON DT,VAL TN,et al. Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release[ J]. J Pharm Sci,2005,91 (1) : 56 - 69.
  • 3MAO SR,XU J,CAI CF,et al. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres[J], lnt J Pharm,2007,334(1 -2):137 - 148.
  • 4SCHLICHER EJAM,POSTMA NS,ZUIDEMA J,et al. Preparation and characterization of poly(d,l-lactic-co-glycolic acid) mi- crospheres containing desferrioxamine [ J ]. lnt J Pharm, 1997, 153:235 - 245.
  • 5LEE YS,LOWE JP,GILBY E,et al. The initial release of eisplatin from poly ( lactide-co-glycolide microspheres [ J ]. lrtt J Pharm ,2010,383 ( 1 - 2 ) :244 - 254.
  • 6BERKLAND C,KIM K,PACK DW. PLGA microsphere size controis drug release rate through several competing factors [ J ]. Pharm Res,2003,20(7) : 1055 - 1062.
  • 7BERKLAND C, KING M, COX A,et al. Precise control of PLG microsphere size provides enhanced control of drug release rate [ J ]. J Control Release,2002,82 ( 1 ) : 137 - 147.
  • 8KLOSE D, SIEPMANN F, ELKHARRAZ K,et al. How porosity and size affect the drug release mechanisms from PLGA-based microparticles[ J]. Int J Pharm ,2006,314 (2) : 198 - 206.
  • 9WANG J,WANG BM,SCHWENDEMAN SP. Characterization of the initial burst release of a model peptide from poly ( D, L-lac- tide-co-glycolide) microspheres [ J ]. J Control Release, 2002,82 (2 -3) :289 -307.
  • 10MESSARITAKI A,BLACK SJ,VAN DER WALLE CF,et al. NMR and confocaI microscopy studies of the mechanisms of burst drug release from PLGA microspheres [ J ]. J Control Release, 2005,108(2 -3) :271 -281.

共引文献19

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部